PRTK Annual Operating Profit
-$46.21 M
-$5.08 M-12.35%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual operaing income is -$46.21 million, with the most recent change of -$5.08 million (-12.35%) on December 31, 2022. During the last 3 years, it has risen by +$69.42 million (+60.04%).PRTK Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly Operating Profit
-$9.41 M
+$6.39 M+40.46%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly operating income is -$9.41 million, with the most recent change of +$6.39 million (+40.46%) on June 30, 2023. Over the past year, it has increased by +$3.76 million (+28.53%).PRTK Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK TTM Operating Profit
-$44.54 M
+$3.76 M+7.78%
30 June 2023
Summary:
As of January 21, 2025, PRTK TTM operating income is -$44.54 million, with the most recent change of +$3.76 million (+7.78%) on June 30, 2023. Over the past year, it has increased by +$23.34 million (+34.38%).PRTK TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.3% | +28.5% | +34.4% |
| 3 y3 years | +60.0% | +49.0% | +52.7% |
| 5 y5 years | +45.3% | +66.0% | +61.5% |
PRTK Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -3574.4% | -120.3% | -224.7% |
Paratek Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$9.41 M(-40.5%) | -$44.54 M(-7.8%) |
| Mar 2023 | - | -$15.80 M(+457.1%) | -$48.30 M(+4.5%) |
| Dec 2022 | -$46.21 M(+12.3%) | -$2.84 M(-82.8%) | -$46.21 M(-34.6%) |
| Sept 2022 | - | -$16.49 M(+25.2%) | -$70.65 M(+4.1%) |
| June 2022 | - | -$13.17 M(-4.0%) | -$67.88 M(+67.1%) |
| Mar 2022 | - | -$13.71 M(-49.7%) | -$40.62 M(-1.2%) |
| Dec 2021 | -$41.13 M(-45.5%) | -$27.28 M(+98.9%) | -$41.13 M(+31.1%) |
| Sept 2021 | - | -$13.72 M(-197.4%) | -$31.38 M(-6.6%) |
| June 2021 | - | $14.09 M(-199.1%) | -$33.61 M(-49.2%) |
| Mar 2021 | - | -$14.22 M(-18.9%) | -$66.15 M(-12.4%) |
| Dec 2020 | -$75.50 M(-34.7%) | -$17.53 M(+9.9%) | -$75.50 M(-7.0%) |
| Sept 2020 | - | -$15.95 M(-13.5%) | -$81.15 M(-13.9%) |
| June 2020 | - | -$18.45 M(-21.8%) | -$94.21 M(-11.0%) |
| Mar 2020 | - | -$23.58 M(+1.7%) | -$105.89 M(-8.4%) |
| Dec 2019 | -$115.63 M(+11.1%) | -$23.18 M(-20.1%) | -$115.63 M(+2.8%) |
| Sept 2019 | - | -$29.01 M(-3.7%) | -$112.50 M(-0.5%) |
| June 2019 | - | -$30.12 M(-9.6%) | -$113.09 M(+2.2%) |
| Mar 2019 | - | -$33.32 M(+66.2%) | -$110.64 M(+6.3%) |
| Dec 2018 | -$104.05 M(+23.3%) | -$20.05 M(-32.3%) | -$104.05 M(-0.7%) |
| Sept 2018 | - | -$29.60 M(+7.0%) | -$104.82 M(+9.7%) |
| June 2018 | - | -$27.67 M(+3.5%) | -$95.54 M(+13.5%) |
| Mar 2018 | - | -$26.73 M(+28.4%) | -$84.15 M(-0.3%) |
| Dec 2017 | -$84.42 M(-23.1%) | -$20.82 M(+2.5%) | -$84.42 M(-6.0%) |
| Sept 2017 | - | -$20.32 M(+24.8%) | -$89.78 M(-3.2%) |
| June 2017 | - | -$16.28 M(-39.7%) | -$92.74 M(-12.7%) |
| Mar 2017 | - | -$27.00 M(+3.1%) | -$106.20 M(-3.3%) |
| Dec 2016 | -$109.83 M(+55.2%) | -$26.18 M(+12.4%) | -$109.83 M(+5.1%) |
| Sept 2016 | - | -$23.28 M(-21.7%) | -$104.50 M(-0.3%) |
| June 2016 | - | -$29.74 M(-2.9%) | -$104.83 M(+16.0%) |
| Mar 2016 | - | -$30.63 M(+46.9%) | -$90.37 M(+27.7%) |
| Dec 2015 | -$70.75 M(+985.2%) | -$20.85 M(-11.7%) | -$70.75 M(+52.3%) |
| Sept 2015 | - | -$23.61 M(+54.5%) | -$46.47 M(+73.9%) |
| June 2015 | - | -$15.28 M(+38.7%) | -$26.72 M(+81.2%) |
| Mar 2015 | - | -$11.01 M(-420.6%) | -$14.74 M(+126.2%) |
| Dec 2014 | -$6.52 M(-73.3%) | $3.44 M(-188.9%) | -$6.52 M(-57.9%) |
| Sept 2014 | - | -$3.87 M(+17.1%) | -$15.47 M(-5.0%) |
| June 2014 | - | -$3.30 M(+18.5%) | -$16.29 M(-2.6%) |
| Mar 2014 | - | -$2.79 M(-49.5%) | -$16.72 M(-31.5%) |
| Dec 2013 | -$24.41 M | -$5.52 M(+17.8%) | -$24.41 M(-3.9%) |
| Sept 2013 | - | -$4.69 M(+25.6%) | -$25.41 M(+60.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2013 | - | -$3.73 M(-64.4%) | -$15.82 M(-8.0%) |
| Mar 2013 | - | -$10.47 M(+60.7%) | -$17.19 M(+45.0%) |
| Dec 2012 | -$11.86 M(+215.0%) | -$6.52 M(-233.0%) | -$11.86 M(>+9900.0%) |
| Sept 2012 | - | $4.90 M(-196.1%) | -$10.00 K(-99.9%) |
| June 2012 | - | -$5.10 M(-0.9%) | -$9.87 M(+41.1%) |
| Mar 2012 | - | -$5.14 M(-196.5%) | -$7.00 M(+85.8%) |
| Dec 2011 | -$3.76 M(-59.2%) | $5.33 M(-207.4%) | -$3.76 M(-67.8%) |
| Sept 2011 | - | -$4.96 M(+123.5%) | -$11.68 M(+23.4%) |
| June 2011 | - | -$2.22 M(+16.2%) | -$9.46 M(+1.8%) |
| Mar 2011 | - | -$1.91 M(-26.2%) | -$9.29 M(+0.8%) |
| Dec 2010 | -$9.22 M(-53.5%) | -$2.59 M(-5.7%) | -$9.22 M(+3.8%) |
| Sept 2010 | - | -$2.74 M(+33.8%) | -$8.88 M(-11.4%) |
| June 2010 | - | -$2.05 M(+11.5%) | -$10.03 M(-34.2%) |
| Mar 2010 | - | -$1.84 M(-18.3%) | -$15.25 M(-23.2%) |
| Dec 2009 | -$19.85 M(+8.4%) | -$2.25 M(-42.2%) | -$19.85 M(-72.7%) |
| Sept 2009 | - | -$3.89 M(-46.5%) | -$72.70 M(-4.7%) |
| June 2009 | - | -$7.27 M(+12.9%) | -$76.26 M(+237.7%) |
| Mar 2009 | - | -$6.44 M(-88.3%) | -$22.58 M(+23.4%) |
| Dec 2008 | -$18.30 M(-50.1%) | -$55.10 M(+639.5%) | -$18.30 M(-155.7%) |
| Sept 2008 | - | -$7.45 M(-116.1%) | $32.88 M(-7.9%) |
| June 2008 | - | $46.41 M(-2250.4%) | $35.72 M(-230.4%) |
| Mar 2008 | - | -$2.16 M(-44.8%) | -$27.38 M(-25.3%) |
| Dec 2007 | -$36.65 M(+11.9%) | -$3.91 M(-15.3%) | -$36.65 M(-11.6%) |
| Sept 2007 | - | -$4.62 M(-72.3%) | -$41.46 M(-7.4%) |
| June 2007 | - | -$16.69 M(+46.1%) | -$44.76 M(+23.6%) |
| Mar 2007 | - | -$11.43 M(+31.0%) | -$36.20 M(+10.6%) |
| Dec 2006 | -$32.74 M(+31.7%) | -$8.72 M(+10.2%) | -$32.74 M(-33.1%) |
| Sept 2006 | - | -$7.92 M(-2.7%) | -$48.92 M(+19.3%) |
| June 2006 | - | -$8.13 M(+2.1%) | -$40.99 M(+24.8%) |
| Mar 2006 | - | -$7.97 M(-68.0%) | -$32.85 M(+32.1%) |
| Dec 2005 | -$24.86 M(+32.4%) | -$24.91 M(<-9900.0%) | -$24.86 M(+27.0%) |
| Sept 2005 | - | $14.00 K(0.0%) | -$19.58 M(+1.4%) |
| June 2005 | - | $14.00 K(0.0%) | -$19.31 M(+1.4%) |
| Mar 2005 | - | $14.00 K(-100.1%) | -$19.05 M(+1.4%) |
| Dec 2004 | -$18.78 M(-1512.0%) | -$19.62 M(-7106.8%) | -$18.78 M(-2335.6%) |
| Sept 2004 | - | $280.00 K(0.0%) | $840.00 K(+50.0%) |
| June 2004 | - | $280.00 K(0.0%) | $560.00 K(+100.0%) |
| Mar 2004 | - | $280.00 K | $280.00 K |
| Dec 2003 | $1.33 M(-122.6%) | - | - |
| Dec 2002 | -$5.88 M(+257.1%) | - | - |
| Dec 2001 | -$1.65 M | - | - |
FAQ
- What is Paratek Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual operating profit year-on-year change?
- What is Paratek Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly operating profit year-on-year change?
- What is Paratek Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals TTM operating profit year-on-year change?
What is Paratek Pharmaceuticals annual operaing income?
The current annual operating profit of PRTK is -$46.21 M
What is the all time high annual operating profit for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual operaing income is $1.33 M
What is Paratek Pharmaceuticals annual operating profit year-on-year change?
Over the past year, PRTK annual operaing income has changed by -$5.08 M (-12.35%)
What is Paratek Pharmaceuticals quarterly operating income?
The current quarterly operating profit of PRTK is -$9.41 M
What is the all time high quarterly operating profit for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly operating income is $46.41 M
What is Paratek Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, PRTK quarterly operating income has changed by +$3.76 M (+28.53%)
What is Paratek Pharmaceuticals TTM operating income?
The current TTM operating profit of PRTK is -$44.54 M
What is the all time high TTM operating profit for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high TTM operating income is $35.72 M
What is Paratek Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, PRTK TTM operating income has changed by +$23.34 M (+34.38%)